Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vacc-4x Re-boosting in HIV-1 Infection
NCT01712256Phase 2Completed
- Sponsor
- Immunor
- Start
- Dec 2012
- Primary completion
- Jan 2014
- Countries
- 5
01
Overview
A Phase 2 trial of Vacc-4x in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Immunor. Started Dec 2012; status: completed.
02
Drugs
Vacc-4x
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01712256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712256.